Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EauLife is a life science company dedicated to the development and commercialization of hydrogen-based therapies for health and wellness. The company focuses on the therapeutic potential of molecular hydrogen, specifically through its proprietary hydrogen-rich water (HRW) technology, to combat oxidative stress and inflammation. EauLife's products are designed to deliver high concentrations of dissolved hydrogen gas, which acts as a selective antioxidant to neutralize harmful reactive oxygen species. The company targets a range of applications, including metabolic health, athletic performance recovery, and general longevity. EauLife positions itself at the intersection of biotechnology and functional wellness, leveraging clinical research to validate the efficacy of hydrogen therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on eauLife.